ArticleCureus2025
The Deadly Itch: A Rare but Fatal Case of Norwegian Scabies.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Norwegian (crusted) scabies is a rare but highly contagious variant of scabies that predominantly affects immunocompromised individuals, such as those with diabetes or neurological disorders. The condition is characterised by hyperkeratotic plaques teeming with mites, often leading to secondary bacterial infections and life-threatening complications. We present a fatal case of Norwegian scabies in a 65-year-old male with epilepsy and diabetes, who developed severe skin infestation, staphylococcal bacteremia, and multi-organ failure. Despite receiving aggressive treatment with oral ivermectin, topical permethrin, and IV antibiotics, the patient deteriorated and succumbed to sepsis. This case highlights the importance of early diagnosis, aggressive management, and strict infection control to prevent adverse outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.